Chemotherapy Complete blood counts Qi-gong therapy Traditional Chinese medicine After surgery, breast cancer patients are offered adjuvant chemotherapy to avoid cancer cell spread. During chemotherapy process, neutrophils could fall relatively, and side effects could spike to the peak. Therefore, the medical care personnel should prevent the progression of the side effects. This study aimed to examine the effects of Chan-Chuang qi-gong therapy on complete blood counts in breast cancer patients treated with chemotherapy. This study used a quasi-experimental design. The experiment group (n = 32) received a 21-day Chan-Chuang qi-gong therapy, whereas the control group (n = 35) did not. White blood cells, platelet, and hemoglobin were measured on the day before chemotherapy and on days 8, 15, and 22 during chemotherapy. According to this study, there were significant differences in white blood cells (F = 115.76, P G .001), platelets (F = 25.29, P G .001), and hemoglobin (F = 15.39, P G .001) over the 3-week therapy between the experiment and control groups. Chan-Chuang qi-gong therapy may decrease leukopenia in breast cancer patients treated with chemotherapy. It is recommended conducting more studies on qi-gong and then introducing it in clinical nursing practice at an appropriate time to promote quality of nursing care and quality of patient life.
cancer death in the United States. 2, 3 Most breast cancer patients have metastases, and distant metastases ultimately develop for most of those who were treated with apparently curative surgery. 4 After surgery, 62% of breast cancer patients received adjuvant chemotherapy to reduce cancer recurrence and metastases. 5 However, the inf liction of the side effects of chemotherapy sometimes may cause cancer patients to reject their chemotherapy. Such side effects include leukopenia, neutropenia, granulocytopenia, thrombocytopenia, and anemia. 6 During chemotherapy process, neutrophils could fall relatively, and side effects could spike to the peak. If neutropenia results in fever, sepsis may rapidly develop, and nearly half such patients may die in 2 hours. 7 Therefore, the medical care personnel should prevent the progression of the side effects of chemotherapy.
According to traditional Chinese medicine (TCM), the major side effects of chemotherapy, such as the inhibition of bone marrow, inf lammation, and body weakness, are caused by external environment. As an example of the external evil-qi, it invades the human body to create excessively abundant pyretic toxicity in the organism and causes vital deregulation and pathological change as well as other vital damage and hepatorenal weakness. The principle of TCM treatment is to restore vital energy for the blood, regulate spleen and stomach, nourish liver and kidney, and alleviate as well as expel pyretic toxicity. 8 Qi-gong, a kind of TCM, called ''guiding'' in ancient China, has many names in Chinese history. In 1979, its name was unified as ''qui-gong'' therapy. 9 Many researchers have pointed out that qi-gong therapy may reduce longstanding pain, 10,11 increase phagocytic activity, 12 improve cardiac and pulmonary functions, 13, 14 affect serum biochemical index, 15, 16 and change electroencephalography. 17 According to TCM, qi-gong therapy functions to regulate the body, mind, spirit, and breathing, because it can directly soothe the central nervous system and especially the sympathetic nervous system through a process of relaxation, entering tranquil state, and regulating respiration. The circulatory system of blood and lymph can be improved in tissues and cells with qi migration. An individual's physiological and biochemical functions, in turn, optimize and thus establish a health cycle.
Chan-Chuang qi-gong therapy, one kind of qi-gong disciplines, has the benefits of strengthening internal qi in the human body to restore vital energy and to preserve health. Its unique properties of little side effects and remarkable ''qifostering and health-promoting'' effects are advocated in practical medicine application. 18 Chan-Chuang qi-gong therapy demands neither ''entering tranquil state,'' artificial modulation of respiration, nor ''integrating spirit,'' 19 However, it is required to keep the whole body in a state of relaxation but with clear consciousness. It is very easy to learn even for a beginner. All one has to do is to stand up at ease, put one's arms as one is holding a tree trunk, breath naturally, and maintain poise. 18, 19 Because cancer patients treated with chemotherapy are usually extremely weak, it is not appropriate for them to engage in complicated qi-gong. Recognizing that Chan-Chuang qi-gong therapy is easy to learn, has no side effects, and is not very strenuous and demanding to fatigue or tire out cancer patients, it is a good candidate as a physical therapy to regain strength and health for cancer patients. Consequently, this study aimed to explore the effects of Chan-Chuang qi-gong therapy on complete blood counts in breast cancer patients treated with chemotherapy.
n Methods
Study Design and Study Sample
This study used a quasi-experimental research design with 2 groups: experimental and control groups. The experimental group received Chan-Chuang qi-gong therapy, whereas the control group did not. Using SSIZE (WHO, 1999) to estimate the sample size, at least 35 subjects for each group were required. All subjects recruited from a 1,820-bed medical center in Taiwan have breast cancer diagnosed by physicians according to the result of pathological examination and about to undergo the first course of chemotherapy. Experimental subjects received their Chan-Chuang qi-gong therapy for 21 days.
Intervention
This study developed a manual of Chan-Chuang qi-gong instructions with graphics demonstrating the actual moves by the authors. Breast cancer patients with chemotherapy are not suitable for practicing complicated qi-gong because of their extreme physical weakness and side effects of treatment. Chan-Chuang qi-gong has the advantage of being easy to learn, having no side effects, and causing no extra physical load to patients. Figure 1 shows a gesture of Chan-Chuang qi-gong: stand up with 2 legs separated at a distance between 2 shoulders, bend the knees slightly, raise both arms horizontally above the chest and below the shoulder in a shape as one is holding a tree trunk, put the palms inward and fingers separated, slightly open the eyes and see the distance, rid of other irrelevant ideas, breathe naturally, and hold the gesture for 15 minutes. When time is up, stand straight slowly, put down the arms gently, and put hands on the waist, then rest for 2 to 3 minutes on the spot. For the purpose of not inf luencing appetite and digestion, Chan-Chuang qi-gong should not be practiced a half hour before and after meals. Chan-Chuang qi-gong can be practiced in any place, indoors or outdoors.
Procedures
Agreement for this study was obtained from the Committee of Quality Improvement of Tri-Service General Hospital. Informed consents were also obtained from all subjects. All subjects were made aware that data collected in the study would remain confidential, and the anonymity would be assured. In addition, subjects were free to withdraw from the study at any time during the study.
Patients who received the first chemotherapy and met the inclusion criteria were enrolled in this study. Then, instruction in Chan-Chuang qi-gong was arranged. During the first 21day chemotherapy treatment cycle, subjects in the experiment group were asked to practice Chan-Chuang qi-gong at least 15 minutes and at most 1 hour everyday. 18, 19 The demographic factors, disease characteristics, and complete blood counts were investigated on the day before and on days 8, 15, and 22 after the beginning of Chan-Chuang qi-gong therapy.
Measures
Demographics in questionnaire included age, education, marital status, religion, socioeconomic status, menstrual status, number of of-age children, and primary caregiver. The medical record of disease conditions included tumor stage, operative type, types of chemotherapy, and medication. In addition to questionnaires, this study used SYSMEX9000 automatic blood analyzer made by San Tung Co. (Taipei, Taiwan) to analyze complete blood counts such as white blood cells (WBCs), platelets, and hemoglobin (Hb). Complete blood counts were measured on the day before the first chemotherapy as the baseline data and on days 8, 15, and 22 during chemotherapy treatment.
Data analysis
The data were analyzed with SPSS (Chicago, Ill) version 11.0. First, descriptive statistics of frequency, percentage, mean, and SD were performed on the demographic data. Afterward, inferential statistics of repeated-measures analysis of variance (ANOVA) and t test were conducted to compare complete blood counts between and within the 2 groups.
n Results
Results of Homogeneity Between the 2 Groups
This study recruited 72 subjects in the beginning. However, one subject withdrew from the control group because of oral ulcer, and 3 withdrew because of fever. One subject withdrew from the experimental group because of physical and mind discomfort. The drop rate was 7%. There were 32 subjects in the experiment group and 35 subjects in the control group in the end. The average age of the subjects was 44 years (SD, 7.51 years) for the experiment group and 49 years (SD, 8.13 years) for the control group. As shown in Table 1 , most subjects (41.8%) were older than 50 years, university or college graduates (38.8%), and premenopause (62.7%). As shown in Table 2 , most subjects were in tumor stage II (53.7%) with a tumor size of 2 to 5 cm (62.7%), had modified radical mastectomy (70.1%) as their breast operation, and did not have radiotherapy before their chemotherapies (74.6%).
Using a # 2 test to evaluate the homogeneity between the demographics of these 2 groups, this study detected no statistically significant difference. This finding indicated that the demographics of experiment and control groups were similar.
Results of Chan-Chuang Qi-Gong Therapy in Complete Blood Cell Counts for the 2 Groups
During the first 21-day chemotherapy, all subjects' complete blood counts, including WBCs, platelets, and Hb, were monitored and examined 4 times, including the baseline and on days 8, 15, and 22 of chemotherapy. To understand the trend of changes, repeated measures ANOVA was used. As shown in Table 3 , there was no significant difference in WBCs between the experiment and control groups (F = 0.186, P 9 .05). Within-group analysis showed significant differences across 4 measurements in WBCs (F = 115.76, P G .001). As shown in Table 4 , there was no significant difference in platelets between the 2 groups (F = 0.334, P 9 .05). Within-group analysis showed significant differences across 4 measurements in platelets (F = 25.29, P G .001). As shown in Table 5 , there was no significant difference in Hb between the 2 groups (F = 0.005, P 9 .05). Within-group analysis showed significant differences across 4 measurements in Hb (F = 15.39, P G .001).
In this study, WBCs were detected at the lowest level on week 2 of chemotherapy with a mean of 1,955 6L for both groups. See Figure 2 for more details. As shown in Figure 3 , the lowest level of platelets in the experiment and control groups was detected on week 1 of chemotherapy, with 189,500 and 194,523 6L, respectively. As shown in Figure 4 , the lowest level of Hb in the experiment and control groups was detected on week 2 of chemotherapy, with 11.42 and 11.32 g/dL, respectively.
To understand single periods of change, complete blood counts were analyzed by independent t test between the 2 groups and paired t test for each group. After finishing the first 21-day chemotherapy, the average of WBCs increased by 416.25 6L for the experiment group but dropped 810.57 6L in the control group, with a significant difference between the 2 groups (t = 3.18, P G .01). The average of platelets increased by 92,531.25 6L in the experiment group and 67,057.14 6L in the control group, with no significant difference between the 2 groups (t = j1.21, P 9 .05). The average of Hb dropped by 0.27 mg/dL in the experiment group and 0.43 mg/dL in the control group, with no significant difference between the 2 groups (t = j0.79, P 9 .05). The experiment group, comparing week 3 with the baseline, showed no significant increase in WBCs (t = 1.326, P 9 .05) and Hb (t = j1.860, P 9 .05), but significant difference in platelets (t = 5.37, P G .001). The control group, after comparing week 3 with the baseline, showed significant decrease in WBCs (t = j4.41, P G .001) and Hb (t = j2.94, P G .01), but increase in platelets (t = 5.59, P G .001). Figure 5 shows the differences of week 3 and baseline in complete blood counts for the 2 groups. n Discussions WBCs, platelets, and Hb of the subjects in the experiment group improved significantly during the first 21-day chemotherapy treatment. WBCs, platelets, but not Hb, of the subjects in the control group also improved during the same period. This result is similar to that in the study of Lee et al. 16 However, they claimed that qi-gong could increase the monocyte and lymphocyte numbers instead of WBCs. According to this study, the complete blood counts of all subjects were all within reference range before chemotherapy started. However, at the end of week 1 during chemotherapy, the average counts of WBCs of all subjects dropped below the reference range. At the end of week 2 during chemotherapy, the average WBCs fell to its lowest. It went back within reference range at the end of week 3. For platelets, at the end of week 1, the average counts dropped below the reference range and fell to its lowest point, but it bounced back within reference range at the end of week 2 and above the reference range at the end of week 3. It is possible that the bounce-back behavior is a result of the inhibition of bone marrow along with the reactive proliferation. For Hb, at the end of week 1, the average dropped below the reference range, fell to its lowest at the end of week 2, and went back within the reference range at the end of week 3.
It is apparent that the subjects had the side effect, inhibition of bone marrow, during chemotherapy. It was most serious by weeks 1 and 2. This finding is similar to that in the study of Dia and Lo 20 in which the patients' WBCs fell between days 9 and 16 during chemotherapy period. This is also in agreement with the results of the study of Miaskowski and Buchsel 6 that pointed out that cancer patients treated with adriamycin and cyclophosphamide during chemotherapy could have side effects such as leukopenia, thrombocytopenia, and anemia, especially leukopenia. The results of this study detected significant differences in WBCs, platelets, and Hb in each group, except for Hb in the control group. During the data collection of this study, 3 subjects in the control group were hospitalized for fever and infection because of excessively low WBCs; they withdrew from the study. As mentioned previously, as long as neutrophils fall relatively and side effects spike to the peak, sepsis could rapidly develop and cause the death of nearly half of patients if not treated promptly. 7 Therefore, it is very important for medical care personnel to alleviate or even prevent the progression of side effects of chemotherapy.
Furthermore, after comparing the differences between weeks 1 and 3 during chemotherapy, a significant downward trend was found for WBCs and Hb of the subjects in the control group, but not in the experiment group. WBCs of the subjects in the experiment group increased more significantly than those of the subjects in the control group. In other words, Chan-Chuang qi-gong might help the subjects to improve the side effects such as decreasing WBCs resulting from chemotherapy. This finding is similar to that in the study of Lan and Chang 21 in which T cells, instead of WBCs, were found to show significant difference. Although there is no significant difference found in the change of platelets and Hb between the 2 groups, experiment subjects demonstrate better improvement in platelets. A possible explanation is that Chan-Chung qi-gong could regulate the body and breathing to increase the function of the circulatory system. 22 Practicing qi-gong could facilitate the circulation of blood and lymph, promote cellular activities naturally, and strengthen the immune systems. 23 n Conclusions
With the practice of Chan-Chuang qi-gong therapy, the cancer patients in this study demonstrated an improvement of the side effect of decreasing WBCs during the first course of chemotherapy. Chan-Chuang qi-gong therapy happens to possess nonaggressive, have a body-mind-spirit overall viewpoint, and be economical and effective. Therefore, it might be a good candidate for complementary intervention for clinical practice to manage the side effects such as leukopenia. However, in this study, the Chan-Chuang qi-gong therapy caused nonsignificant effects in the platelet and Hb. It is recommended that more scientific studies on Chan-Chuang qi-gong therapy be conducted before implementation. The use of randomized method would enable more rigorous evaluation of the effect of Chang-Chuang qi-gong practice. In addition, a prolonged period of Chang-Chuang qi-gong therapy might enable more appropriate timing to detect the effect in platelet and Hb.
